[Swift card here]

Michael T. Speidel, M.D.

Born and raised in Poland and Austria, he graduated in 1968 from prestigious "Marcinek High" in Poznan, Poland. Dr. Speidel obtained his M.D. degree from the Poznan University of Medical Sciences in 1976 and started his work as a Teaching Assistant at the Department of Anatomy, Poznan University of Medical Sciences (1976-1978). He completed his internship at the Poznan Clinics and University Hospitals (1977-1978). He emigrated to the United States in 1978 where he continued his education and post-doctoral training at the Medical College of Georgia (1978-1985), University of South Carolina (1985-1986), University of Alabama at Birmingham (1986-88) and Harvard University, School of Medicine in Boston at the Joint Center for Radiation Therapy, Dana Farber Cancer Institute and New England Deaconess Hospital (1988-1990). He is an author and co-author of over 16 articles and abstracts published in scientific journals on the subjects of thrombosis and fibrinolysis, biology of lipoproteins, high risk factors, cell biology, immunology, monoclonal therapy of cancer patients, radio-biology and global health.

In 1990 Dr. Speidel formed a partnership firm Boston International Healthcare Corporation and became its first President & CEO, specializing in advising American pharmaceutical companies to enter open markets in Central Europe and Turkey. In his subsequent private business activities, Dr. Speidel was responsible for handling regulatory issues in the various countries in which his firms operated, organizing clinical trials, developing pre-marketing intelligence, establishing distribution networks for generic and plasma products and lecturing on bio-technology issues related to plasma derivates products. He served as a Consultant to many American and European pharmaceuticals companies and to several Ministers of Health in Poland, Slovakia, Hungary and Romania. In 1996 he has formed a second consulting firm, Centurion Pharmaceuticals which specialized in advising American and European pharmaceutical companies on health-care issues in Turkey, China, Cambodia, Singapore, Indonesia, Thailand, and the Middle East.

Dr. Speidel was instrumental in helping to establish the Bone Marrow Transplantation Center in Krakow, Poland (1992-1998) and the Kidney Transplantation Program in Poznan, Poland (1997). For four years, Dr. Speidel was a Vice President and National Director of the Polish American Congress in Boston and Chief Editor of Life of Polonia newsletter. Currently, he is an Advisor to the American-Polish Advisory Council of Washington, DC and a Board Member of the American Friends of Cracow Leukemia Foundation, New York, NY.

From: resume